COMMENTARY

• Type 2 Diabetic Mellitus: Expanding Therapeutics Strategy (3)
  July 4, 2005

• Former Reviewers' Interviews Make OPIR Report Exciting
  June 27, 2005

• Type 2 Diabetic Mellitus: Expanding Therapeutics Strategy (2)
  June 27, 2005

• Type 2 Diabetic Mellitus: Expanding Therapeutics Strategy (1)
  June 20, 2005

• Special Contribution
  May 16, 2005

• Japan's Most Admired Pharma Companies P. Reed Maurer President, NPP
  April 18, 2005

• PRTM Shows Results of Investigational Drug Survey
  March 14, 2005

• ＜Special Comtribution＞
  March 7, 2005

• ＜Special Comtribution＞
  March 7, 2005

• JPMA Update (12)
  November 22, 2004

• JPMA Pudate(11)
  November 15, 2004

• JPMA Update (10)
  November 8, 2004

• JPMA Update (9)
  November 1, 2004

• JPMA Update (8)
  October 25, 2004

• JPMA Update (7)
  October 18, 2004

• JPMA Update (6)
  October 11, 2004

• ＜Special Contribution＞
  October 4, 2004

• JPMA Update (5)
  October 4, 2004

• JPMA Update(4)
  September 27, 2004

• JPMA Update (3)
  September 20, 2004

ページ